Pathological Myeloid Activation After Sepsis and Trauma
The goal of this observational study is to better understand what happens to circulating blood after a patient experiences severe trauma injury. The main questions it aims to answer are: Is severe human trauma associated with specific patterns of development in the hematopoietic stem cells of these patients? and Does the initial severe trauma injury create immunosuppression and increase risk of in-hospital sepsis? Participants in study will give blood samples and a waste sample of bone marrow at time of operative repair of traumatic orthopedic injuries, supply medical information and participate in surveys and assessments during recovery from their injury(ies). Researchers will compare severe trauma injury patients to elective hip repair patients to see if immunosuppression and specific development patterns occur in the trauma patient versus the otherwise healthy hip surgery patient.
Conditions:
🦠 Trauma Injury 🦠 Sepsis 🦠 Immunosuppression 🦠 Chronic Critical Illness
🗓️ Study Start (Actual) 1 September 2022
🗓️ Primary Completion (Estimated) 1 September 2027
✅ Study Completion (Estimated) 30 September 2028
👥 Enrollment (Estimated) 255
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Gainesville, Florida, United States

📋 Eligibility Criteria

Description

  • Trauma population
  • Inclusion Criteria:

    • 1. All adults age ≥ 18 years
    • 2. Blunt and/or penetrating trauma resulting in long bone or pelvic fractures requiring open reduction internal fixation or closed reduction percutaneous pinning
    • 3. Blunt and/or penetrating trauma patient with a. Injury Severity Score (ISS) greater than or equal to 25 b. ISS \> 15 and one of the following: i. \> 4 units of packed red blood cell or \>3 units of whole blood or \>1500 ml of autogenous blood product in the first 24 hours of admission ii. AIS (acute injury score) \> 2 spine iii. Shock on arrival (SBP \< 90)
    • OR
    • c. ISS \> 15 and two of the following: i. Age \> 55 ii. AIS \> 2 chest iii. +ethyl alcohol on arrival iv. Any red blood cell transfusion in first 24 hours

    Exclusion Criteria:

    • 1. Patients not expected to survive greater than 48 hours.
    • 2. Prisoners.
    • 3. Pregnancy.
    • 4. Patients receiving chronic corticosteroids or immunosuppression therapies.
    • 5. Previous bone marrow transplantation.
    • 6. Patients with End Stage Renal Disease.
    • 7. Patients with any pre-existing hematological disease.
    • 8. Patients deemed to be futile care or have advanced directives limiting resuscitative efforts.
    • 9. Patients with severe congestive heart failure (NY Heart Association Class IV).
    • 10. Known HIV infection with CD4+ (clusters of differentiation) count \<200 cells/mm3
    • 11. Chronic liver disease with MELD (Model for End-Stage Liver Disease) score ≥15
    • Elective Hip population

    Inclusion Criteria:

    • 1. All adults (age ≥18)
    • 2. Patient undergoing elective hip repair for non-infectious reasons.
    • 3. Ability to obtain Informed Consent prior to operation.

    Exclusion Criteria:

    • 1. Pregnancy.
    • 2. Prisoners.
    • 3. Patients receiving chronic corticosteroids or immunosuppression therapies.
    • 4. Pre-existing conditions such as pathological fractures, cancer, history of HIV, or history of connective tissue disease.
    • 5. Previous bone marrow transplantation.
    • 6. Patients with End Stage Renal Disease.
    • 7. Patients with any pre-existing hematological disease.
    • 8. Patients with known active/symptomatic COVID-19 (Coronavirus disease).
Ages Eligible for Study: 18 Years to 100 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 7 November 2022
  • First Submitted that Met QC Criteria 7 November 2022
  • First Posted 15 November 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 8 April 2024
  • Last Update Posted 9 April 2024
  • Last Verified April 2024